Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
about
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementNovel Immune Check-Point Regulators in Tolerance MaintenanceUpdate on CD40 and CD154 blockade in transplant modelsBiologics in organ transplantationA novel monoclonal antibody to CD40 prolongs islet allograft survivalEffects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigsCTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8Tolerogenic therapies in transplantation.In vitro testing of an anti-CD40 monoclonal antibody, clone 2C10, in primates and pigs.CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory moleculesCD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell ProliferationCombined costimulatory and leukocyte functional antigen-1 blockade prevents transplant rejection mediated by heterologous immune memory alloresponsesPrimate models in organ transplantationLessons and limits of mouse models.Costimulation Blockade in Kidney Transplantation: An UpdateImpact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.Costimulation blockade: current perspectives and implications for therapy.B-cell regulation and its application to transplantation.Biologic agents in islet transplantation.Targeting co-stimulatory pathways: transplantation and autoimmunity.T-cell costimulatory blockade in organ transplantation.Potential and limitations of regulatory T-cell therapy in solid organ transplantation.Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.Belatacept prophylaxis against organ rejection in adult kidney-transplant recipients.First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotraT Cell Cosignaling Molecules in Transplantation.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon modelAbsence of donor CD40 protects renal allograft epithelium and preserves renal function.ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates.Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.Rapamycin and CTLA4Ig synergize to induce stable mixed chimerism without the need for CD40 blockade.
P2860
Q26769878-454F3F6B-0E01-40E5-A3C7-0B6FB47797CEQ26782789-913A1DF2-D409-4E08-AF3B-6156BA539436Q26798362-11C06FF0-51D9-49E0-9795-47B222EFA14CQ26829578-98A78436-D5BB-4CC5-8344-E42658F18E7BQ30417821-8F48B143-2B53-46A2-A604-A1B47D57446DQ34243893-4FAA2466-177D-422E-ABFC-FB1D8F1C105DQ34336527-58DF0D35-7515-435D-9CE6-86744BDDD0BFQ35202459-8771718F-8073-4C1C-AF02-A2F3A90B61D0Q36069444-2FBAAF41-D581-49B6-A4C3-78E2A93A064DQ36102133-F5081D63-4A2B-4A15-9AC9-073A31654952Q36289120-D7F15D15-B10E-42FF-8F11-EFBAF28F9AF0Q36339318-44D25EC3-548B-4E83-8B31-94F726052A5BQ36633574-4BDB3961-744F-42B7-B331-E4B20866117CQ36989992-CFEEB1F3-5269-4B12-AC99-5A6073FF0BA3Q37122367-A6F9B8CA-CF78-4CBB-9A1C-95CF538D1B81Q37340373-5B10E064-6451-4790-8E0B-9EE152103159Q37375148-5FF4FAE1-5C3A-4893-AB13-0A7DD0A12967Q37660263-898AF4AA-1D32-4D79-B042-DB02D69E4E40Q38057977-831CFC43-F090-432D-98CF-21B8C7AA77A6Q38126085-76B0A99B-3E57-486C-9B19-7103A2A9DF86Q38126884-6E2F1C1C-FA4B-4635-8B3F-AEED6D88E726Q38150101-9610F423-2565-40F0-8118-4FA91CC367A6Q38168010-C6C0C430-B38E-4A6A-A2F3-6445D1940EEFQ38235166-ACD8AA14-DCD8-4DDC-B4D5-43FD0C5EDB3EQ38445344-E38AB8D7-5CD4-4C13-A776-675ACB9FC316Q38675622-FD44B39A-FFED-472A-8862-22209B9BF6D2Q38751293-CE8F6618-7A9F-4B54-AF4D-96544C8CFE73Q38837473-FBE105B9-8BBF-40A7-B87A-6966CE2BEE63Q39161011-846ADB67-8836-4276-8213-FEEF7DF9FC24Q41723730-71CDA3B1-6CC3-45FE-B719-2FB587A054F4Q44561822-D249233B-1BCD-4341-89A8-D28C6362C744Q48032381-3625FFBE-4254-4DE6-BF57-7C3A562C111FQ50614844-6E9CC8A6-60D7-4E72-A3F6-2C886E1F084FQ50948280-C35E037D-A6BA-42A2-A73D-C3B7FF7982C5Q54283965-EFCD66AC-443E-4B11-8C16-F52DC5C886F6
P2860
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
@ast
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
@en
type
label
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
@ast
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
@en
prefLabel
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
@ast
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
@en
P2093
P2860
P1476
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
@en
P2093
A P Turner
C P Larsen
E A Strobert
F V Leopardi
I R Badell
J M Robertson
K A Reimann
P2860
P304
P356
10.1111/J.1600-6143.2011.03736.X
P407
P577
2011-09-15T00:00:00Z